Bioline Rx Financial Overview
Bioline Rx's market cap is currently 44.38M. The company's EPS TTM is 0; its P/E ratio is -1.97; Bioline Rx is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is -0.32. See an overview of income statement, balance sheet, and cash flow financials.
